Changes in breast cancer mortality in Navarre (Spain) after introduction of a screening programme

Journal of Medical Screening

Volumn 14, Issue 1, 2007, Pages 14-20

  Ascunce, Elizaga N ^a   Moreno Iribas, C ^a   Urtiaga, A Barcos ^a   Ardanaz, E ^a   Sanz, M Ederra ^a   Castilla, J ^a   Egues N ^a  

^a INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER SCREENING; CONTROLLED STUDY; FEMALE; HEALTH PROGRAM; HUMAN; POPULATION RESEARCH; PREVALENCE; SPAIN;

ADULT; AGE DISTRIBUTION; AGED; BREAST NEOPLASMS; CARCINOMA; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; MODELS, STATISTICAL; SPAIN;

EID: 33947317566     PISSN: 09691413     EISSN: 14755793     Source Type: Journal    
DOI: 10.1258/096914107780154558     Document Type: Article

References (24)

1. Boyle P, Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann Oncol 2005;16:481-8
2. Althuis MD, Dozier JM, Anderson WF, Devesa SS, Brinton LA. Global trends in breast cancer incidence and mortality 1973-1997. Int J Epidemiol 2005;34:405-12
3. Gabe R, Duffy W. Evaluation of service screening mammography in practice: the impact on breast cancer mortality. Ann Oncol 2005;16(Suppl 2):153-62
4. Freedman DA, Petitti DB, Robins JM. On the efficacy of screening for breast cancer. Int J Epidemiol 2004;33:43-55
5. Botha JL, Bray F, Sankila R, Parkin DM. Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer 2003;39:1718-29
6. Berry DA, Cronin KA, Plevritis SK, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 2005;353:1784-92
7. De Waard F, Kirpatrick A, Perry NM, Tomberg S, Tubiana M, de Wolf C. Breast cancer screening in the framework of the Europe against Cancer programme. Eur J Cancer Prev 1994;3(Suppl 1):3-5
8. Broeders MJM, Scharpantgen A, Ascunce N, et al. Comparison of early performance indicators for screening projects within the European Breast Cancer Network: 1989-2000. Eur J Cancer Prev 2005;14:107-16
9. Ascunce N, Barcos A, Ederra M, et al. Programa de detección precoz de cáncer de mama. Resultados de proceso e indicadores de impacto (1990-2002) [Breast cancer screening program. Results of the process and impact indicators (1990-2002)]. An Sist Sanit Navar 2004;27:319-33
10. Perry N, Broeders M, de Wolf C, Tornberg S, Holland R, von Karsa L. European Guidelines For Quality Assurance In Breast Cancer Screening And Diagnosis 4th edn. Luxembourg: Office for Official Publications of the European Communities, 2006
11. Jensen OM, Parkin DM, MacLennan R, Muir CS, Skeek RG. Registros de Cáncer. Principios y Métodos [Cancer Registries. Principles and Methods]. Lyon: IARC-Pub. Cient. No. 95, 1995
12. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation test for joinpoint regression with applications to cancer rates. Stat Med 2000;19:335-51
13. WHO. Statistical Information System (WHOSIS). Access date: January 2006. Available at http://www-dep.iarc.fr/
14. Edwards B, Bown M, Wingo P, et al. Annual Report to the Nation on the Status of Cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 2005;97:1407-27
15. López-Abente G, Pollán M, Aragonés N, et al. La situación del cáncer en España [The Cancer Situation in Spain]. Madrid: Ministerio de Sanidad y Consumo-Centro de Publicaciones, 2005
16. Nyström L, Andersson I, Bjurstam N, Frisell J, Nordenskjöld B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 2002;359:909-19
17. Otto SJ, Fracheboud J, Looman CW, et al. Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review. Lancet 2003;361: 1411-17
18. Olsen AH, Njor SH, Veijborg I, et al. Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study. Br Med J 2005;330(7485):220, doi: 10.1136/ bmj.38313.639236.82
19. Blanks R, Moss SM, McGahan CE, Quinn MJ, Babb PJ. Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality. Br Med J 2000;321:665-9, doi: 10.1136/bmj.321.7262.665
20. Tabar L, Yen MF, Vitak B, Chen HT, Smith RA, Duffy SW. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet 2003;361:1405- 10
21. Gorini G, Zappa M, Miccinesi G, Paci E, Seniori Costantini A. Breast cancer mortality trends in two areas of the province of Florence, Italy, where screening programmes started in the 1970s and 1990s. Br J Cancer 2004;90:1780-3
22. Van den Akker-van Marle ME, Reep-van den Bergh CMN, Polder JJ, et al. Cost-Effectiveness Analysis of Breast Cancer Screening in European Pilot Projects. Evaluation of the Early Detection Programme for Breast Cancer in Navarra, Spain. Rotterdam: Erasmus University Rotterdam-Department of Public Health, 1997
23. Van den Akker-van Marle ME, Reep-van den Bergh CM, Boer R, et al. Breast cancer screening in Navarra: interpretation of a high detection rate at the first screening round and a low rate at the second round. Int J Cancer 1997;73(4):464-9
24. Fernandez E, González JR, Borrás JM, Moreno V, Sánchez V, Peris M. Recent decline in cancer mortality in Catalonia (Spain). A joinpoint regression analysis. Eur J Cancer 2001;37:2222-8